International Medical Innovations renamed PreMD
This article was originally published in Clinica
IMI International Medical Innovations, the Toronto, Canada-based maker of the PREVU skin sterol test to predict heart disease, is to change its name to PreMD in September. President and CEO Dr Brent Norton said the new name better reflected the company's focus on predictive medicine. The company has a pipeline of non-invasive cancer detection tests.
You may also be interested in...
The C-suite leaders schemed to falsely record shipments of unwanted products to distributors as sales so the company could meet revenue projections, the government charged.
Gallium has been approved as a diagnostic agent by the US agency to help early detection of prostate cancer spread in patients who qualify for treatment with surgery or radiation therapy.
A joint report by the US Government Accountability Office and the National Academy of Sciences slams the FDA for dawdling on final software as a medical device rules.